DK0816413T3 - Farmaceutisk præparat indeholdende rent polylactid og et hydrofilt eller lipofilt lægemiddel - Google Patents

Farmaceutisk præparat indeholdende rent polylactid og et hydrofilt eller lipofilt lægemiddel

Info

Publication number
DK0816413T3
DK0816413T3 DK97202586T DK97202586T DK0816413T3 DK 0816413 T3 DK0816413 T3 DK 0816413T3 DK 97202586 T DK97202586 T DK 97202586T DK 97202586 T DK97202586 T DK 97202586T DK 0816413 T3 DK0816413 T3 DK 0816413T3
Authority
DK
Denmark
Prior art keywords
hydrophilic
pharmaceutical preparation
preparation containing
containing pure
lipophilic drug
Prior art date
Application number
DK97202586T
Other languages
Danish (da)
English (en)
Inventor
Walter Prikoszovich
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016840A external-priority patent/GB9016840D0/en
Priority claimed from GB909016882A external-priority patent/GB9016882D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0816413T3 publication Critical patent/DK0816413T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/88Post-polymerisation treatment
    • C08G63/90Purification; Drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08Lactones or lactides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97202586T 1990-08-01 1991-07-29 Farmaceutisk præparat indeholdende rent polylactid og et hydrofilt eller lipofilt lægemiddel DK0816413T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909016840A GB9016840D0 (en) 1990-08-01 1990-08-01 Improvements in or relating to organic compounds
GB909016882A GB9016882D0 (en) 1990-08-01 1990-08-01 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
DK0816413T3 true DK0816413T3 (da) 2005-08-29

Family

ID=26297417

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97202586T DK0816413T3 (da) 1990-08-01 1991-07-29 Farmaceutisk præparat indeholdende rent polylactid og et hydrofilt eller lipofilt lægemiddel
DK91112725T DK0469520T3 (da) 1990-08-01 1991-07-29 Fremgangsmåde til fremstilling af rent polylactid

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK91112725T DK0469520T3 (da) 1990-08-01 1991-07-29 Fremgangsmåde til fremstilling af rent polylactid

Country Status (27)

Country Link
EP (2) EP0816413B1 (2)
JP (1) JP3137368B2 (2)
KR (1) KR100255904B1 (2)
AT (1) AT402503B (2)
AU (1) AU650277B2 (2)
CA (1) CA2048200C (2)
CH (1) CH683772A5 (2)
CY (1) CY1986A (2)
DE (1) DE4124468B4 (2)
DK (2) DK0816413T3 (2)
ES (2) ES2243966T3 (2)
FI (2) FI108040B (2)
FR (1) FR2665453B1 (2)
GB (1) GB2246573B (2)
GR (1) GR3026322T3 (2)
HK (1) HK11797A (2)
HU (1) HUT59837A (2)
IE (1) IE66185B1 (2)
IL (1) IL99007A (2)
IT (1) IT1252944B (2)
LU (1) LU87985A1 (2)
MY (1) MY108621A (2)
NO (1) NO912960D0 (2)
NZ (1) NZ239184A (2)
PH (1) PH31047A (2)
PT (1) PT98491B (2)
TW (2) TW282477B (2)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560929A (en) * 1986-08-18 1996-10-01 The Dow Chemical Company Structured copolymers and their use as absorbents, gels and carriers of metal ions
US5527524A (en) * 1986-08-18 1996-06-18 The Dow Chemical Company Dense star polymer conjugates
US5225521A (en) * 1991-12-31 1993-07-06 E. I. Du Pont De Nemours And Company Star-shaped hydroxyacid polymers
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5525357A (en) * 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
JPH06116381A (ja) * 1992-10-09 1994-04-26 Mitsui Toatsu Chem Inc ポリヒドロキシカルボン酸の精製方法
DE4412317A1 (de) * 1993-04-21 1994-10-27 Basf Ag Polylactid mit verbreiterter Molmassenverteilung
US5359026A (en) * 1993-07-30 1994-10-25 Cargill, Incorporated Poly(lactide) copolymer and process for manufacture thereof
US5496923A (en) * 1993-09-20 1996-03-05 Mitsui Toatsu Chemicals, Inc. Purification process of aliphatic polyester
CN1074923C (zh) 1993-11-19 2001-11-21 詹森药业有限公司 微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
FI955320A7 (fi) * 1994-03-07 1995-11-24 Univ Michigan Bioaktiivisia ja/tai kohdennettuja dendriimikonjugaatteja
JP4854114B2 (ja) 1998-09-11 2012-01-18 シュミドマイヤー,ゲルハルド 生物学的に活性なインプラント
US6362308B1 (en) 2000-08-10 2002-03-26 Alkermes Controlled Therapeutics Inc. Ii Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
US7067611B2 (en) 2001-07-10 2006-06-27 Kureha Corporation Polyhydroxycarboxylic acid and its production process
FR2830448B1 (fr) * 2001-10-10 2004-03-19 Pf Medicament Microspheres biodegradables a liberation prolongee et leur procede de preparation
BRPI0213226B1 (pt) * 2001-10-10 2016-03-01 Pf Medicament processo de preparação de uma composição farmacêutica sob forma de microesferas com liberação prolongada de um princípio ativo hidrossolúvel, e, microesferas
GB0226993D0 (en) * 2002-11-19 2002-12-24 Novartis Ag Organic compounds
AU2013204972B2 (en) * 2002-11-19 2016-04-21 Novartis Ag Pharmaceutical composition comprising octreotide microparticles
US20040097419A1 (en) * 2002-11-19 2004-05-20 Holger Petersen Organic compounds
PT1787658E (pt) 2005-11-10 2012-06-22 Chemi Spa Formulações de libertação sustentada de análogos de somatostatina inibidores da hormona do crescimento
CN101193531B (zh) 2006-11-29 2010-12-01 富准精密工业(深圳)有限公司 散热装置
RU2459840C2 (ru) * 2007-12-31 2012-08-27 Самъянг Корпорейшн АМФИФИЛЬНЫЙ СОПОЛИМЕР ВЫСОКОЙ ЧИСТОТЫ, СОДЕРЖАЩИЙ ГИДРОФОБНЫЙ БЛОК ИЗ α-ГИДРОКСИКИСЛОТЫ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ
US20100256746A1 (en) * 2009-03-23 2010-10-07 Micell Technologies, Inc. Biodegradable polymers
JP5594996B2 (ja) 2009-09-14 2014-09-24 三菱重工業株式会社 航空機の操縦システム
DE202011110978U1 (de) 2010-06-21 2017-11-27 Lg Chem, Ltd. Polylactidharz mit ausgezeichneter Wärmebeständigkeit
EP2455414A1 (de) * 2010-11-17 2012-05-23 Evonik Röhm GmbH Verfahren zur Herstellung von hochmolekularen, resorbierbaren Polyestern, die mit dem Verfahren herstellbaren hochmolekularen resorbierbaren Polyester und deren Verwendung
EP2455415A1 (de) * 2010-11-17 2012-05-23 Evonik Röhm GmbH Verfahren zur Herstellung von niedermolekularen, resorbierbaren Polyestern, die mit dem Verfahren herstellbaren niedermolekularen resorbierbaren Polyester und deren Verwendung
CN105820332B (zh) * 2015-01-09 2018-06-29 北京化工大学 一种星形聚氨基酸和星形聚氨基酸载药纳米胶束及制备方法
US10556999B2 (en) 2016-01-29 2020-02-11 Tolmar, Inc. Purification and decolorization of polymers
KR102688314B1 (ko) * 2017-08-31 2024-07-26 에보닉 코포레이션 개선된 재흡수성 중합체 정제 방법
GR1009392B (el) * 2017-09-19 2018-10-25 Φαρματεν Αβεε Φαρμακευτικο σκευασμα που περιλαμβανει ενα πεπτιδικο φαρμακο και μεθοδος για την παρασκευη αυτου
GB2568526A (en) * 2017-11-20 2019-05-22 Rebio Tech Oy Composition
CN112940234B (zh) * 2021-01-28 2022-05-03 广东粤港澳大湾区黄埔材料研究院 一种高纯度聚乙丙交酯的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1467970A (en) * 1975-05-02 1977-03-23 Ici Ltd Purification of polyethers
US4273920A (en) * 1979-09-12 1981-06-16 Eli Lilly And Company Polymerization process and product
CH656884A5 (de) * 1983-08-26 1986-07-31 Sandoz Ag Polyolester, deren herstellung und verwendung.
CA1256638A (en) * 1984-07-06 1989-06-27 Motoaki Tanaka Polymer and its production
CA1268481A (en) * 1984-11-13 1990-05-01 Atsushi Aoshima Process for purification of polyether
JP2551756B2 (ja) * 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
JPH0610252B2 (ja) * 1985-08-21 1994-02-09 和光純薬工業株式会社 重合体の製造法
DE3641692A1 (de) * 1986-12-06 1988-06-09 Boehringer Ingelheim Kg Katalysatorfreie resorbierbare homopolymere und copolymere
DE3708916A1 (de) * 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
JP2714454B2 (ja) * 1988-11-07 1998-02-16 三井東圧化学株式会社 生体吸収性ポリエステルの製造方法
CA2040141C (en) * 1990-04-13 2002-05-14 Minoru Yamada Biodegradable high-molecular polymers, production and use therof

Also Published As

Publication number Publication date
ITRM910553A0 (it) 1991-07-23
DK0469520T3 (da) 1998-09-23
FI108040B (fi) 2001-11-15
JP3137368B2 (ja) 2001-02-19
FR2665453B1 (fr) 1995-01-27
MY108621A (en) 1996-10-31
IT1252944B (it) 1995-07-05
HU912452D0 (en) 1991-12-30
FR2665453A1 (fr) 1992-02-07
CA2048200C (en) 1999-06-29
AT402503B (de) 1997-06-25
NZ239184A (en) 1994-09-27
GB9116396D0 (en) 1991-09-11
EP0469520B1 (en) 1998-02-25
TW282477B (2) 1996-08-01
AU650277B2 (en) 1994-06-16
ITRM910553A1 (it) 1993-01-23
EP0816413A3 (en) 1998-11-11
ES2243966T3 (es) 2005-12-01
GB2246573B (en) 1994-05-11
KR100255904B1 (ko) 2000-05-01
ES2112259T3 (es) 1998-04-01
HK11797A (en) 1997-02-14
IE66185B1 (en) 1995-12-13
AU8143091A (en) 1992-02-27
EP0469520A2 (en) 1992-02-05
FI913641A0 (fi) 1991-07-30
KR920003990A (ko) 1992-03-27
ATA151591A (de) 1996-10-15
CA2048200A1 (en) 1992-02-02
DE4124468A1 (de) 1992-02-06
GR3026322T3 (en) 1998-06-30
FI20011189L (fi) 2001-06-05
EP0469520A3 (en) 1992-10-07
TW218025B (2) 1993-12-21
IL99007A0 (en) 1992-07-15
HUT59837A (en) 1992-07-28
FI913641L (fi) 1992-02-02
EP0816413B1 (en) 2005-06-08
LU87985A1 (fr) 1993-02-15
EP0816413A2 (en) 1998-01-07
CH683772A5 (de) 1994-05-13
GB2246573A (en) 1992-02-05
CY1986A (en) 1997-09-05
IE912697A1 (en) 1992-02-12
FI111268B (fi) 2003-06-30
JPH0641279A (ja) 1994-02-15
PT98491A (pt) 1992-06-30
NO912960D0 (no) 1991-07-30
DE4124468B4 (de) 2010-10-28
PH31047A (en) 1998-02-03
IL99007A (en) 1994-12-29
PT98491B (pt) 1997-12-31

Similar Documents

Publication Publication Date Title
DK0816413T3 (da) Farmaceutisk præparat indeholdende rent polylactid og et hydrofilt eller lipofilt lægemiddel
FI954767A7 (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
EE03110B1 (et) Steroidi estrid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid
DK314789D0 (da) Quinolinetheralkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse
IT8822770A0 (it) Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
EP0237073A3 (en) Il-1alpha derivatives and drugs
FI20030210A7 (fi) Suun kautta annettavat farmaseuttiset valmisteet sekä menetelmä niiden valmistamiseksi
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
PH25104A (en) Acyl derivatives and pharmaceutical preparation thereof
GB2229094B (en) Pharmaceutical capsules containing ranitidine
FI891774L (fi) Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi
IL88846A0 (en) Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
EP0448091A3 (en) Pharmaceutical composition containing slightly water-soluble drug
DK48790A (da) Steroidforbindelse og farmaceutisk praeparat indeholden en saadan forbindelse
DK127691A (da) Mucoadhaesivt baerestof og farmaceutisk doseringsform indeholdende dette baerestof
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DE68903536D1 (de) Pharmazeutische granula und daraus hergestellte tabletten.
FI932388A7 (fi) 8-eeni-19,11b-siltasteroidit, niiden valmistus ja niitä sisältävät far maseuttiset valmisteet
NO892764L (no) Medikamentell administreringsform for droevtyggere.
KR900012897A (ko) 구아니딘 유도체 및 이를 함유하는 약제학적 조성물
DK559088D0 (da) Farmaceutisk praeparat indeholdende et sympathominetisk laegemiddel og piperidinoalkanol
DK650089A (da) Furanalkylketoner og farmaceutiske praeparater deraf
PH24960A (en) Acyl derivatives and pharmaceutical preparation thereof
DK340388D0 (da) Aminocyklopentylaetere, fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser